These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16413174)

  • 1. A yeast-based model of alpha-synucleinopathy identifies compounds with therapeutic potential.
    Griffioen G; Duhamel H; Van Damme N; Pellens K; Zabrocki P; Pannecouque C; van Leuven F; Winderickx J; Wera S
    Biochim Biophys Acta; 2006 Mar; 1762(3):312-8. PubMed ID: 16413174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-Synuclein budding yeast model: toxicity enhanced by impaired proteasome and oxidative stress.
    Sharma N; Brandis KA; Herrera SK; Johnson BE; Vaidya T; Shrestha R; Debburman SK
    J Mol Neurosci; 2006; 28(2):161-78. PubMed ID: 16679556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional mitochondria are required for alpha-synuclein toxicity in aging yeast.
    Büttner S; Bitto A; Ring J; Augsten M; Zabrocki P; Eisenberg T; Jungwirth H; Hutter S; Carmona-Gutierrez D; Kroemer G; Winderickx J; Madeo F
    J Biol Chem; 2008 Mar; 283(12):7554-60. PubMed ID: 18192273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregation of α-synuclein in S. cerevisiae is associated with defects in endosomal trafficking and phospholipid biosynthesis.
    Soper JH; Kehm V; Burd CG; Bankaitis VA; Lee VM
    J Mol Neurosci; 2011 Mar; 43(3):391-405. PubMed ID: 20890676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation, lipid raft interaction and traffic of alpha-synuclein in a yeast model for Parkinson.
    Zabrocki P; Bastiaens I; Delay C; Bammens T; Ghillebert R; Pellens K; De Virgilio C; Van Leuven F; Winderickx J
    Biochim Biophys Acta; 2008 Oct; 1783(10):1767-80. PubMed ID: 18634833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cell-based model of alpha-synucleinopathy for screening compounds with therapeutic potential of Parkinson's disease.
    Zhao DL; Zou LB; Zhou LF; Zhu P; Zhu HB
    Acta Pharmacol Sin; 2007 May; 28(5):616-26. PubMed ID: 17439717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yeast reveals similar molecular mechanisms underlying alpha- and beta-synuclein toxicity.
    Tenreiro S; Rosado-Ramos R; Gerhardt E; Favretto F; Magalhães F; Popova B; Becker S; Zweckstetter M; Braus GH; Outeiro TF
    Hum Mol Genet; 2016 Jan; 25(2):275-90. PubMed ID: 26586132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aegeline, a natural product from the plant Aegle marmelos, mimics the yeast SNARE protein Sec22p in suppressing α-synuclein and Bax toxicity in yeast.
    Derf A; Sharma A; Bharate SB; Chaudhuri B
    Bioorg Med Chem Lett; 2019 Feb; 29(3):454-460. PubMed ID: 30579794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of alpha-synuclein aggregation and synergistic toxicity with protein tau in yeast.
    Zabrocki P; Pellens K; Vanhelmont T; Vandebroek T; Griffioen G; Wera S; Van Leuven F; Winderickx J
    FEBS J; 2005 Mar; 272(6):1386-400. PubMed ID: 15752356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding Caffeine's Role in Attenuating the Toxicity of α-Synuclein Aggregates: Implications for Risk of Parkinson's Disease.
    Kardani J; Roy I
    ACS Chem Neurosci; 2015 Sep; 6(9):1613-25. PubMed ID: 26167732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Saccharomyces cerevisiae strain unable to store neutral lipids is tolerant to oxidative stress induced by α-synuclein.
    Sere YY; Regnacq M; Colas J; Berges T
    Free Radic Biol Med; 2010 Dec; 49(11):1755-64. PubMed ID: 20850523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models.
    Cooper AA; Gitler AD; Cashikar A; Haynes CM; Hill KJ; Bhullar B; Liu K; Xu K; Strathearn KE; Liu F; Cao S; Caldwell KA; Caldwell GA; Marsischky G; Kolodner RD; Labaer J; Rochet JC; Bonini NM; Lindquist S
    Science; 2006 Jul; 313(5785):324-8. PubMed ID: 16794039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease.
    Flower TR; Chesnokova LS; Froelich CA; Dixon C; Witt SN
    J Mol Biol; 2005 Sep; 351(5):1081-100. PubMed ID: 16051265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of endogenous Hsp104 chaperone in yeast models of sporadic and familial Parkinson's disease.
    Gade VR; Kardani J; Roy I
    Int J Biochem Cell Biol; 2014 Oct; 55():87-92. PubMed ID: 25161148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-synuclein aggregation in neurodegenerative diseases and its inhibition as a potential therapeutic strategy.
    Paleologou KE; Irvine GB; El-Agnaf OM
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1106-10. PubMed ID: 16246056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation and clearance of alpha-synuclein aggregates demonstrated by time-lapse imaging.
    Opazo F; Krenz A; Heermann S; Schulz JB; Falkenburger BH
    J Neurochem; 2008 Jul; 106(2):529-40. PubMed ID: 18410502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different 8-hydroxyquinolines protect models of TDP-43 protein, α-synuclein, and polyglutamine proteotoxicity through distinct mechanisms.
    Tardiff DF; Tucci ML; Caldwell KA; Caldwell GA; Lindquist S
    J Biol Chem; 2012 Feb; 287(6):4107-20. PubMed ID: 22147697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease.
    Azeredo da Silveira S; Schneider BL; Cifuentes-Diaz C; Sage D; Abbas-Terki T; Iwatsubo T; Unser M; Aebischer P
    Hum Mol Genet; 2009 Mar; 18(5):872-87. PubMed ID: 19074459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel protein phosphatases as modifiers of alpha-synuclein aggregation in yeast.
    Brás IC; Tenreiro S; Silva AM; Outeiro TF
    FEMS Yeast Res; 2018 Dec; 18(8):. PubMed ID: 30277516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in alpha-synuclein transgenic C. elegans.
    Kuwahara T; Koyama A; Koyama S; Yoshina S; Ren CH; Kato T; Mitani S; Iwatsubo T
    Hum Mol Genet; 2008 Oct; 17(19):2997-3009. PubMed ID: 18617532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.